Crystalvue Medical Corporation (TPEX:6527)
Taiwan
· Delayed Price · Currency is TWD 75.50
-1.50 (-1.95%)
At close: Mar 9, 2026
Crystalvue Medical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 146.98 | 127.15 | 103.4 | 115.03 | 77.24 | Upgrade
|
| Depreciation & Amortization | 17.82 | 27 | 28.09 | 25.37 | 40.34 | Upgrade
|
| Other Amortization | - | 2.35 | 1.09 | 0.79 | 0.54 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.28 | - | - | - | -13.95 | Upgrade
|
| Stock-Based Compensation | - | 3.88 | 19.91 | - | - | Upgrade
|
| Other Operating Activities | 3.47 | -5.94 | -5.59 | 4.17 | 6.45 | Upgrade
|
| Change in Accounts Receivable | -56.86 | -62.85 | 36.55 | -50.42 | -13.33 | Upgrade
|
| Change in Inventory | 6.41 | 26.11 | -29.2 | -61.17 | -37.63 | Upgrade
|
| Change in Accounts Payable | -0.41 | 21.06 | 0.45 | 16.56 | -20.19 | Upgrade
|
| Change in Unearned Revenue | -13.53 | 1.63 | 1.47 | 1.31 | 6.94 | Upgrade
|
| Change in Other Net Operating Assets | 35.53 | 12.67 | -2.14 | 0.13 | 16.84 | Upgrade
|
| Operating Cash Flow | 139.13 | 153.06 | 154.01 | 51.76 | 63.26 | Upgrade
|
| Operating Cash Flow Growth | -9.10% | -0.62% | 197.53% | -18.17% | -24.28% | Upgrade
|
| Capital Expenditures | -184.11 | -130.44 | -4.37 | -7.52 | -351.17 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.28 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1.15 | -1.6 | -4.18 | -1.49 | 68.37 | Upgrade
|
| Investment in Securities | - | - | 0.17 | -0.59 | - | Upgrade
|
| Other Investing Activities | - | 3.41 | -0.75 | 5.08 | 88.88 | Upgrade
|
| Investing Cash Flow | -184.98 | -128.63 | -9.12 | -4.52 | -193.91 | Upgrade
|
| Long-Term Debt Repaid | -6.76 | -6.57 | -6.38 | -6.2 | -6.03 | Upgrade
|
| Net Debt Issued (Repaid) | -6.76 | -6.57 | -6.38 | -6.2 | -6.03 | Upgrade
|
| Issuance of Common Stock | - | 2.73 | 15.05 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -11.97 | - | Upgrade
|
| Common Dividends Paid | -57.02 | -52.3 | -56.76 | -46.3 | -33.41 | Upgrade
|
| Financing Cash Flow | -63.78 | -56.13 | -48.09 | -64.47 | -39.44 | Upgrade
|
| Net Cash Flow | -109.62 | -31.71 | 96.8 | -17.23 | -170.09 | Upgrade
|
| Free Cash Flow | -44.98 | 22.62 | 149.64 | 44.24 | -287.91 | Upgrade
|
| Free Cash Flow Growth | - | -84.89% | 238.26% | - | - | Upgrade
|
| Free Cash Flow Margin | -4.74% | 2.61% | 18.16% | 5.56% | -39.90% | Upgrade
|
| Free Cash Flow Per Share | -1.74 | 0.88 | 5.92 | 1.73 | -11.35 | Upgrade
|
| Cash Interest Paid | 0.45 | 0.63 | 0.82 | 1 | 1.17 | Upgrade
|
| Cash Income Tax Paid | 28.56 | 38.17 | 21.94 | 23.24 | 25.48 | Upgrade
|
| Levered Free Cash Flow | -77.59 | -13 | 115.66 | 7.49 | -226.8 | Upgrade
|
| Unlevered Free Cash Flow | -77.31 | -12.61 | 116.17 | 8.12 | -226.07 | Upgrade
|
| Change in Working Capital | -28.86 | -1.38 | 7.12 | -93.59 | -47.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.